Lack of a genetic association between the CTLA-4 gene and Graves' Disease in Koreans

Thyroid

Volumn 16, Issue 3, 2006, Pages 237-241

  Cho, Hyun Jung ^a   Chung, Jae Hoon ^a   Kim, In Sook ^a   Kim, Hee Jin ^a   Cho, Seung Hee ^b   Ki, Chang Seok ^a   Kim, Jong Won ^a,b  

^a Department of Laboratory Medicine ^*  (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

3' UNTRANSLATED REGION; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CTLA 4 GENE; ETHNOLOGY; EXON; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; VALIDATION PROCESS;

3' UNTRANSLATED REGIONS; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33645508182     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.237     Document Type: Article

References (25)

1. Chung JH, Kim BJ, Choi YH, Shin MH, Kim SH, Min YK, Lee MS, Lee MK, Kim KW 1999 Prevalence of thyrotoxicosis and hypothyroidism in the subjects for healthy check-up. J Korean Soc Endocrinol 14:301-313.
2. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693.
3. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH 1999 The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 8:1195-1199.
4. Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW 2003 Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J Hum Genet 48:236-242.
5. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664.
6. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SH 2001 Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 86:626-630.
7. Vaidya B, Pearce S 2004 The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur J Endocrinol 150:619-626.
8. Alegre ML, Frauwirth KA, Thompson CB 2001 T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1:220-228.
9. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW 1995 Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988.
10. Kouki T, Gardine CA, Yanagawa T, Degroot LJ 2002 Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 25:208-213.
11. Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P, Pearce SH 2003 CTLA4 gene and Graves' disease: Association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol (Oxf) 58:732-735.
12. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146.
13. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov W 2000 Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 70:214-218.
14. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T 1997 CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7:843-846.
15. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S 1998 Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47:128-129.
16. Adams AB, Shirasugi N, Jones TR, Durham MM, Strobert EA, Cowan S, Rees P, Hendrix R, Price K, Kenyon NS, Hagerty D, Townsend R, Hollenbaugh D, Pearson TC, Larsen CP 2005 Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 174:542-550.
17. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H 2001 CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Clin Immunol 101:361-365.
18. Yung E, Cheng PS, Fok TF, Wong GW 2002 CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol (Oxf) 56:649-653.
19. Ueda H, Howson JM, Esposito L, Reward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Geneva G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Hewlett S, Healy B, Nutland S, Ranee HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511.
20. Dupont WD, Plummer WD, Jr. 1990 Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128.
21. Gough SC 2000 The genetics of Graves' disease. Endocrinol Metab Clin North Am 29:255-266.
22. Clark RG 1998 Thyroid histological changes in lambs from iodine-supplemented and untreated ewes. N Z Vet J 46:223-225.
23. Furugaki K, Shirasawa S, Ishikawa N, Ito K, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T 2004 Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet 49:166-168.
24. Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, Gajewski T, Bluestone J 2001 Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc 33:209-211.
25. Munthe-Kaas MC, Carlsen KH, Helms PJ, Gerritsen J, Why te M, Feijen M, Skinningsrud B, Main M, Kwong GN, Lie BA, Lodrup Carlsen KC, Undlien DE 2004 CTLA-4 polymorphisms in allergy and asthma and the TH1/TH2 paradigm. J Allergy Clin Immunol 114:280-287.